Study identifier:NIS-RDE-SYM-2009/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
A 6 months NIS to evaluate the use of rescue medication and quality of life in adult asthmatic subjects treated with Symbicort® SMART® 1-2 inhalations b.i.d. as maintenance therapy plus additional inhalations as-needed, compared to patients treated with a free combination of an inhaled glucocorticosteroid and an inhaled long acting ß2-agonist plus as needed inhalations of a short acting ß2 agonist.
asthma
-
No
-
All
500
Observational
18 Years +
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Mar 2011 by AstraZeneca Pharmaceuticals
AstraZeneca Pharmaceuticals
CLINRESEARCH GMBH
No locations available
Arms | Assigned Interventions |
---|---|
1 Asthma patient with specific treatment | - |
2 Asthma patient on different specific treatment compared to the other group | - |